Healthy high growth potential
Résultats
4
2 nouveau
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
4 entreprises
| Entreprise | Dernier prix | 7D Retour | Retour 1 an | Capitalisation boursière | Cible des analystes | Évaluation | Croissance | Rendement des dividendes | L'industrie | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GUBRA Nouveau | DKK 400.40 | 5.1% | 4.3% | DKK 6.6b | DKK 501.00 | 24.3 | 108.4% | 0% | Pharmaceuticals & Biotech | ||
DONKEY Nouveau | DKK 8.50 | -4.0% | 32.8% | DKK 340.3m | DKK 9.50 | 172.7 | 99.5% | n/a | Transportation | ||
BIOPOR | DKK 1.25 | -0.4% | -2.7% | DKK 599.1m | DKK 1.75 | 16.1 | 66.2% | n/a | Pharmaceuticals & Biotech | ||
CBRAIN | DKK 77.70 | 15.3% | -59.1% | DKK 1.5b | DKK 90.00 | 32.4 | 27.1% | 1.3% | Software |
Page 1 of 1